BOTULINUMTOXIN TYPE A – 100 Units

Generic Name: onabotulinumtoxinA
Strength & Packaging: 100 Units per single-dose vial
Dosage Form: Sterile, vacuum-dried lyophilized powder for reconstitution prior to injection. Official reference labeling for the 100-unit format specifies reconstitution with preservative-free 0.9% Sodium Chloride Injection, USP. Potency units are product-specific and not interchangeable with other botulinum toxin preparations.

Product Overview

BotulinumToxin Type A 100 Units is a prescription neurotoxin preparation used in carefully selected medical settings for conditions involving excessive muscle activity or glandular stimulation. In official labeling for onabotulinumtoxinA, it is described as an acetylcholine release inhibitor and neuromuscular blocking agent supplied in a single-dose vial for professional use.

Description

This product is a purified botulinum toxin type A preparation intended for reconstitution and injection by qualified healthcare professionals. It is used in treatment protocols where temporary chemodenervation is clinically appropriate. Depending on the licensed product and jurisdiction, botulinum toxin type A may be used for disorders such as chronic migraine, spasticity, cervical dystonia, axillary hyperhidrosis, blepharospasm, strabismus, and selected bladder disorders.

Indications

Indications may vary by product license and country. Reference labeling for onabotulinumtoxinA 100 Units includes use in:

• Overactive bladder and neurologic detrusor overactivity
• Chronic migraine prophylaxis in adults
• Spasticity in appropriate patients
• Cervical dystonia
• Severe primary axillary hyperhidrosis
• Blepharospasm and strabismus
•  

Dosage & Administration

• For professional administration only
• Supplied as a lyophilized powder and must be reconstituted with preservative-free 0.9% Sodium Chloride Injection, USP before use
• Dose, dilution, injection sites, and retreatment interval depend on the indication, anatomic site, severity, and individual patient response
• When initiating treatment, official labeling recommends using the lowest recommended dose and following indication-specific guidance
• Product units are not interchangeable across different botulinum toxin brands or formulations
•  

Mechanism of Action

Botulinum toxin type A works by blocking the release of acetylcholine at cholinergic nerve terminals. This reduces signal transmission to the target muscle or gland, producing a temporary reduction in muscle contraction or secretory activity.

Precautions

Use with caution in patients with:

• Pre-existing swallowing or breathing difficulties
• Known hypersensitivity to botulinum toxin products or formulation components
• Infection at the intended injection site
• Clinical situations where spread of toxin effect could increase risk

Official labeling warns that toxin effects may spread beyond the injection site and can lead to serious swallowing, speech, or breathing difficulties. Immediate medical attention is advised if these occur.

Side Effects

Adverse effects vary by indication and treatment area. Reported reactions with botulinum toxin type A products include:

• Injection-site pain
• Headache
• Neck pain
• Muscular weakness
• Eyelid ptosis
• Dysphagia
• Localized discomfort or site-related reactions
•  

Storage

• Store unopened vials refrigerated at 2°C to 8°C
• Do not use beyond the labeled expiration date
• Reconstituted product may be stored refrigerated at 2°C to 8°C for up to 24 hours until use, according to reference labeling